Philippe Camus, M.D.

Dijon, France

Both apps are now back!

Back

The Drug-Induced Respiratory Disease Website and App

XIV.a

XIV - Hemoglobinopathies - Abnormal hemoglobin states (acquired)

Methemoglobinemia

Last update 16/10/2014

See also under XIVa. Known since the 1940s (PMID 18883450). Comprehensive list of causal drugs and chemicals available at PMID 1564446. Methemoglobin is the oxidized (Fe3+) species of hemoglobin (Fe2+). Patients present with slate-grey cyanosis, low SpO2, normal SaO2 and PaO2. Normally, methemoglobin is <1%. Levels above 40% can be life-threatening, producing pulmonary edema, cardiovascular collapse (PMID 17122537) CNS disturbances and death. Management includes i.v. methylene blue. A possible rebound increase in MeHb upon treatment requires close monitoring. Excess methylene blue can also produce methemoglobinemia

Causative drugs

90

Frequency - Incidence

Incidence of respiratory adverse event(s) due to the specific drug as assessed by number of reported/published cases in the literature. Red digits in stars indicate: 0 = Very rare, questionable signal · 1 = < 10 cases · 2 = 10-50 cases · 3 = 50–100 cases · 4 = 100-200 cases · 5 = >200 cases

I.a
I.b
I.d
I.j
I.af
II.a
II.b
III.a
III.b
IV.c
IV.n
IV.q
V.a
VIII.c
VIII.h
X.m
X.u
X.ac
XI.s
XII.m
XIV.a
XIV.b
XV.x
XVI.ab
XVII.p
Loading more…